To identify effective therapies against sulfur mustard (SM)-induced skin injuries, various animals have been used to assess the cutaneous pathology and related histopathological changes of SM injuries. However, these efforts to establish relevant skin injury endpoints for efficacy studies have been limited mainly due to the restricted assess of SM. Therefore, we employed the SM analog nitrogen mustard (NM), a primary vesicating and bifunctional alkylating agent, to establish relevant endpoints for efficient efficacy studies. Our published studies show that NM (3.2 mg) exposure for 12–120 h in both the hairless SKH-1 and haired C57BL/6 mice caused clinical sequelae of toxicity similar to SM exposure in humans. The NM-induced cutaneous pathology-related structural changes were further analyzed in this study and quantified morphometrically (as percent length or area of epidermis or dermis) of skin sections in mice showing these lesions. H&E stained skin sections of both hairless and haired mice showed that NM (12–120 h) exposure caused epidermal histopathological effects such as increased epidermal thickness, epidermal-dermal separation, necrotic/dead epidermis, epidermal denuding, scab formation, parakeratosis (24–120 h), hyperkeratosis (12–120 h), and acanthosis with hyperplasia (72–120 h). Similar NM exposure in both mice caused dermal changes including necrosis, edema, increase in inflammatory cells, and red blood cell extravasation. These NM-induced cutaneous histopathological features are comparable to the reported lesions from SM exposure in humans and animal models. This study advocates the usefulness of these histopathological parameters observed due to NM exposure in screening and optimization of rescue therapies against NM and SM skin injuries.
References
[1]
Balali-Mood M, Hefazi M (2005) The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 19: 297–315.
[2]
Emadi SN, Aslani J, Poursaleh Z, Izadi M, Soroush M, et al. (2012) Comparison late cutaneous complications between exposure to sulfur mustard and nerve agents. Cutan Ocul Toxicol 31: 214–219.
[3]
Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM (2010) Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol 30: 627–643.
[4]
Naraghi ZS, Mansouri P, Mortazavi M (2005) A clinicopathological study on acute cutaneous lesions induced by sulfur mustard gas (yperite). Eur J Dermatol 15: 140–145.
[5]
Wormser U, Sintov A, Brodsky B, Casillas RP, Nyska A (2004) Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions. Arch Toxicol 78: 156–166.
[6]
Smith KJ, Smith WJ, Hamilton T, Skelton HG, Graham JS, et al. (1998) Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard. Am J Dermatopathol 20: 22–28.
[7]
Kehe K, Balszuweit F, Steinritz D, Thiermann H (2009) Molecular toxicology of sulfur mustard-induced cutaneous inflammation and blistering. Toxicology 263: 12–19.
[8]
Benson JM, Seagrave J, Weber WM, Santistevan CD, Grotendorst GR, et al. (2011) Time course of lesion development in the hairless guinea-pig model of sulfur mustard-induced dermal injury. Wound Repair Regen 19: 348–357.
[9]
Graham JS, Schoneboom BA (2013) Historical perspective on effects and treatment of sulfur mustard injuries. Chem Biol Interact.
[10]
Shakarjian MP, Heck DE, Gray JP, Sinko PJ, Gordon MK, et al. (2010) Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure. Toxicol Sci 114: 5–19.
[11]
Joseph LB, Gerecke DR, Heck DE, Black AT, Sinko PJ, et al. (2011) Structural changes in the skin of hairless mice following exposure to sulfur mustard correlate with inflammation and DNA damage. Exp Mol Pathol 91: 515–527.
[12]
Dachir S, Cohen M, Fishbeine E, Sahar R, Brandies R, et al. (2010) Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods. Skin Res Technol 16: 114–124.
[13]
Lomash V, Deb U, Rai R, Jadhav SE, Vijayaraghavan R, et al. (2011) Designing of mouse model: a new approach for studying sulphur mustard-induced skin lesions. Burns 37: 851–864.
[14]
Wormser U, Brodsky B, Reich R (2002) Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch Toxicol 76: 119–121.
[15]
Tewari-Singh N, Jain AK, Inturi S, White CW, Agarwal R (2013) Clinically-Relevant Cutaneous Lesions by Nitrogen Mustard: Useful Biomarkers of Vesicants Skin Injury in SKH-1 Hairless and C57BL/6 Mice. PLoS One 8: e67557.
[16]
Tewari-Singh N, Rana S, Gu M, Pal A, Orlicky DJ, et al. (2009) Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice. Toxicol Sci 108: 194–206.
[17]
Jain AK, Tewari-Singh N, Orlicky DJ, White CW, Agarwal R (2011) 2-Chloroethyl ethyl sulfide causes microvesication and inflammation-related histopathological changes in male hairless mouse skin. Toxicology 282: 129–138.
[18]
Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, et al. (2013) A clinicopathological approach to sulfur mustard-induced organ complications: a major review. Cutan Ocul Toxicol 32: 304–324.
[19]
Song J, Shea CR (2010) Benign versus malignant parakeratosis: a nuclear morphometry study. Mod Pathol 23: 799–803.
[20]
Sharma M, Vijayaraghavan R, Agrawal OP (2010) Comparative toxic effect of nitrogen mustards (HN-1, HN-2, and HN-3) and sulfur mustard on hematological and biochemical variables and their protection by DRDE-07 and its analogues. Int J Toxicol 29: 391–401.
Wang GQ, Xia ZF (2007) Tissue injury by hot fluid containing nitrogen mustard. Burns 33: 923–926.
[23]
Alexander SF (1947) Medical report on the Bari Harbor mustard casualties. Mil Surg 101: 1–17.
[24]
Watson AP, Griffin GD (1992) Toxicity of vesicant agents scheduled for destruction by the Chemical Stockpile Disposal Program. Environ Health Perspect 98: 259–280.
[25]
Wormser U (1991) Toxicology of mustard gas. Trends Pharmacol Sci 12: 164–167.
[26]
Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, et al. (1997) Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci 14: 126–135.
Hayden PJ, Petrali JP, Stolper G, Hamilton TA, Jackson GR Jr, et al.. (2009) Microvesicating effects of sulfur mustard on an in vitro human skin model. Toxicol In Vitro.
[29]
Hess JF, FitzGerald PG (2007) Treatment of keratin intermediate filaments with sulfur mustard analogs. Biochem Biophys Res Commun 359: 616–621.
[30]
Anumolu SS, Menjoge AR, Deshmukh M, Gerecke D, Stein S, et al. (2011) Doxycycline hydrogels with reversible disulfide crosslinks for dermal wound healing of mustard injuries. Biomaterials 32: 1204–1217.
[31]
Mol MA, van den Berg RM, Benschop HP (2009) Involvement of caspases and transmembrane metalloproteases in sulphur mustard-induced microvesication in adult human skin in organ culture: directions for therapy. Toxicology 258: 39–46.
[32]
Wormser U, Langenbach R, Peddada S, Sintov A, Brodsky B, et al. (2004) Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol Appl Pharmacol 200: 40–47.
[33]
Hardej D, Billack B (2007) Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity. Toxicol Ind Health 23: 209–221.
[34]
Kan RK, Pleva CM, Hamilton TA, Anderson DR, Petrali JP (2003) Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol Pathol 31: 185–190.
[35]
Kehe K, Szinicz L (2005) Medical aspects of sulphur mustard poisoning. Toxicology 214: 198–209.
[36]
Dorandeu F, Taysse L, Boudry I, Foquin A, Herodin F, et al. (2011) Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse. (I) Development of a model for screening studies in skin decontamination and protection. Hum Exp Toxicol 30: 470–490.
[37]
Petrali JP, Oglesby-Megee S (1997) Toxicity of mustard gas skin lesions. Microsc Res Tech 37: 221–228.
[38]
Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, et al. (2011) Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics. Crit Rev Toxicol 41: 384–403.
[39]
Ghanei M, Poursaleh Z, Harandi AA, Emadi SE, Emadi SN (2010) Acute and chronic effects of sulfur mustard on the skin: a comprehensive review. Cutan Ocul Toxicol 29: 269–277.
[40]
Poursaleh Z, Ghanei M, Babamahmoodi F, Izadi M, Harandi AA, et al. (2012) Pathogenesis and treatment of skin lesions caused by sulfur mustard. Cutan Ocul Toxicol 31: 241–249.
[41]
Arroyo CM, Broomfield CA, Hackley BE Jr (2001) The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology. Int J Toxicol 20: 281–296.
[42]
Sabourin CL, Danne MM, Buxton KL, Casillas RP, Schlager JJ (2002) Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J Biochem Mol Toxicol 16: 263–272.
